NYSE:VRX VALEANT PHARMACEUTICALS INTL I
ALGORITHM 100% ACCURATE CLINTON TO WIN U.S ELECTIONS 2016
Valeant is a speculative stock cannot ever be a strong buy until it solves its debt issues; the upgrade you refer to was given several months ago before shares rallied to $32. At that price Morgan Stanley upgraded Valeant and we sold reversing to the short side. Biotech stocks are going to crash - refer to our calls on $ACAD, $IBB, $ILMN, $BLUE, $AGIO $KITE $VRX $AMGN $BIIB just to name a few
@stockmarketLIVE, What are your thinking now? I see you have made some amazing calls. Congrats!
@timwest, we do not invest in companies with corrupt management